HEMOPOESIS INDUCERS AND THEIR ANALOGUES IN THE TREATMENT OF HEMATOLOGICAL TOXICITY OF CHEMOTHERAPY IN PATIENTS WITH NON-HODGKIN LYMPHOMAS
Keywords:
granulocyte colony stimulating factor, hematological toxicity, hematopoiesis inducers, hemocomponent therapy, non-Hodgkin lymphomas, polychemotherapyAbstract
Hematological toxicity continues to be one of the urgent problems of modern chemotherapy for non-Hodgkin lymphomas (NHL). It seems interesting to study new generics and indirect hematopoietic inducers, which will significantly reduce the cost of the therapy and increase its availability for this category of patients. Studies have shown the high efficiency of the generics of known drugs used to restore hematological parameters in patients with NHL. Their effect was more pronounced in comparison with the blood component therapy using erythrocyte suspension and plasma transfusion enriched with platelet concentrate.
